AA
EXAS

AQR Arbitrage’s Exact Sciences EXAS Stock Holding History

AQR Arbitrage’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-191,853
Closed -$19.5M – 572
2025
Q4 		$19.5M Buy
+191,853
New +$15.4M 0.41% 58
2020
Q1 		– Sell
-16,069
Closed -$1.48M – 577
2019
Q4 		$1.48M Buy
+16,069
New +$1.41M 0.03% 281

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

AQR Arbitrage's EXAS Position: Q1 2026 in Review

AQR Arbitrage sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 191,853 shares — an estimated $19.5M sold.

AQR Arbitrage first reported a position in EXAS in Q4 2019 and held it in 2 quarters. The position peaked at $19.5M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • AQR Arbitrage reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • AQR Arbitrage sold 191,853 Exact Sciences shares in Q1 2026, an estimated $19.5M.
  • AQR Arbitrage first reported a position in Exact Sciences in Q4 2019 and held it in 2 quarters.
  • AQR Arbitrage's Exact Sciences position peaked at $19.5M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on AQR Arbitrage's 13F filing for Q1 2026, filed 15 May 2026.